Literature DB >> 23616155

Sodium valproate use is associated with reduced parietal lobe thickness and brain volume.

Heath R Pardoe1, Anne T Berg, Graeme D Jackson.   

Abstract

OBJECTIVE: We hypothesized that total brain volume, white matter volume, and lobar cortical thickness would be different in epilepsy patients. We studied valproate relative to nonvalproate by using patients with epilepsy and healthy controls.
METHODS: Patients with focal intractable epilepsy from a tertiary epilepsy center were the primary group for analysis. A confirmatory analysis was carried out in an independent group of subjects imaged as part of a community-based study of childhood-onset epilepsy. Total brain volume; white matter volume; and frontal, parietal, occipital, and temporal lobe thickness were measured by processing whole-brain T1-weighted MRI using FreeSurfer 5.1.
RESULTS: Total brain volume, white matter volume, and parietal thickness were reduced in the valproate group relative to controls and nonvalproate users (valproate, n = 9; nonvalproate, n = 27; controls, n = 45; all male). These findings were confirmed in an independent group (valproate, n = 7; nonvalproate, n = 70; controls, n = 20; all male).
CONCLUSIONS: Sodium valproate use in epilepsy is associated with parietal lobe thinning, reduced total brain volume, and reduced white matter volume. LEVEL OF EVIDENCE: This study provides Class IV evidence that use of valproate in epilepsy is associated with reduced parietal lobe thickness, total brain volume, and white matter volume.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23616155      PMCID: PMC3908352          DOI: 10.1212/WNL.0b013e318292a2e5

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  14 in total

1.  EEG-fMRI of idiopathic and secondarily generalized epilepsies.

Authors:  Khalid Hamandi; Afraim Salek-Haddadi; Helmut Laufs; Adam Liston; Karl Friston; David R Fish; John S Duncan; Louis Lemieux
Journal:  Neuroimage       Date:  2006-04-19       Impact factor: 6.556

2.  fMRI "deactivation" of the posterior cingulate during generalized spike and wave.

Authors:  John S Archer; David F Abbott; Anthony B Waites; Graeme D Jackson
Journal:  Neuroimage       Date:  2003-12       Impact factor: 6.556

3.  Generalized epileptic discharges show thalamocortical activation and suspension of the default state of the brain.

Authors:  J Gotman; C Grova; A Bagshaw; E Kobayashi; Y Aghakhani; F Dubeau
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-10       Impact factor: 11.205

4.  Reversible pseudoatrophy of the brain and mental deterioration associated with valproate treatment.

Authors:  R Guerrini; A Belmonte; R Canapicchi; C Casalini; E Perucca
Journal:  Epilepsia       Date:  1998-01       Impact factor: 5.864

5.  Measuring the thickness of the human cerebral cortex from magnetic resonance images.

Authors:  B Fischl; A M Dale
Journal:  Proc Natl Acad Sci U S A       Date:  2000-09-26       Impact factor: 11.205

Review 6.  Neuroconnectivity and valproic acid: the myelin hypothesis.

Authors:  Ivana Rosenzweig; Zoran Vukadinovic; Anthony J Turner; Marco Catani
Journal:  Neurosci Biobehav Rev       Date:  2012-05-28       Impact factor: 8.989

7.  Dynamic mapping of human cortical development during childhood through early adulthood.

Authors:  Nitin Gogtay; Jay N Giedd; Leslie Lusk; Kiralee M Hayashi; Deanna Greenstein; A Catherine Vaituzis; Tom F Nugent; David H Herman; Liv S Clasen; Arthur W Toga; Judith L Rapoport; Paul M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

Review 8.  Basic pharmacology of valproate: a review after 35 years of clinical use for the treatment of epilepsy.

Authors:  Wolfgang Löscher
Journal:  CNS Drugs       Date:  2002       Impact factor: 5.749

9.  Differential cognitive and behavioral effects of topiramate and valproate.

Authors:  K J Meador; D W Loring; J F Hulihan; M Kamin; R Karim
Journal:  Neurology       Date:  2003-05-13       Impact factor: 9.910

10.  Cognitive function at 3 years of age after fetal exposure to antiepileptic drugs.

Authors:  Kimford J Meador; Gus A Baker; Nancy Browning; Jill Clayton-Smith; Deborah T Combs-Cantrell; Morris Cohen; Laura A Kalayjian; Andres Kanner; Joyce D Liporace; Page B Pennell; Michael Privitera; David W Loring
Journal:  N Engl J Med       Date:  2009-04-16       Impact factor: 91.245

View more
  23 in total

1.  Regional brain volumes and cognition in childhood epilepsy: does size really matter?

Authors:  Frank A Zelko; Heath R Pardoe; Sarah R Blackstone; Graeme D Jackson; Anne T Berg
Journal:  Epilepsy Res       Date:  2014-02-19       Impact factor: 3.045

2.  Objective PET study of glucose metabolism asymmetries in children with epilepsy: Implications for normal brain development.

Authors:  Vinod K Pilli; Jeong-Won Jeong; Praneetha Konka; Ajay Kumar; Harry T Chugani; Csaba Juhász
Journal:  Hum Brain Mapp       Date:  2018-08-23       Impact factor: 5.038

3.  Cortical thickness in childhood left focal epilepsy: Thinning beyond the seizure focus.

Authors:  Emanuel M Boutzoukas; Jason Crutcher; Eduardo Somoza; Leigh N Sepeta; Xiaozhen You; William D Gaillard; Gregory L Wallace; Madison M Berl
Journal:  Epilepsy Behav       Date:  2019-12-06       Impact factor: 2.937

4.  Community-informed connectomics of the thalamocortical system in generalized epilepsy.

Authors:  Zhengge Wang; Sara Larivière; Qiang Xu; Reinder Vos de Wael; Seok-Jun Hong; Zhongyuan Wang; Yun Xu; Bin Zhu; Neda Bernasconi; Andrea Bernasconi; Bing Zhang; Zhiqiang Zhang; Boris C Bernhardt
Journal:  Neurology       Date:  2019-08-12       Impact factor: 9.910

5.  Cortical thickness asymmetries and surgical outcome in neocortical epilepsy.

Authors:  David O Kamson; Vinod K Pilli; Eishi Asano; Jeong-Won Jeong; Sandeep Sood; Csaba Juhász; Harry T Chugani
Journal:  J Neurol Sci       Date:  2016-06-29       Impact factor: 3.181

6.  Resting-state fMRI revealed different brain activities responding to valproic acid and levetiracetam in benign epilepsy with central-temporal spikes.

Authors:  Qirui Zhang; Fang Yang; Zheng Hu; Zhiqiang Zhang; Qiang Xu; Mantini Dante; Han Wu; Zhipeng Li; Qian Li; Kai Li; Guangming Lu
Journal:  Eur Radiol       Date:  2016-08-23       Impact factor: 5.315

7.  Neurodevelopment in new-onset juvenile myoclonic epilepsy over the first 2 years.

Authors:  Jack J Lin; Kevin Dabbs; Jeffrey D Riley; Jana E Jones; Daren C Jackson; David A Hsu; Carl E Stafstrom; Michael Seidenberg; Bruce P Hermann
Journal:  Ann Neurol       Date:  2014-08-18       Impact factor: 10.422

8.  Brain functional and structural characteristics of patients with seizure recurrence following drug withdrawal.

Authors:  Ge Tan; Xiuli Li; Deng Chen; Haijiao Wang; Qiyong Gong; Ling Liu
Journal:  Neuroradiology       Date:  2021-07-01       Impact factor: 2.804

9.  Automated analysis of cortical volume loss predicts seizure outcomes after frontal lobectomy.

Authors:  Alexander C Whiting; Marcia Morita-Sherman; Manshi Li; Deborah Vegh; Brunno Machado de Campos; Fernando Cendes; Xiaofeng Wang; William Bingaman; Lara E Jehi
Journal:  Epilepsia       Date:  2021-03-23       Impact factor: 5.864

10.  Ganglion cell complex thickness changes in patients with different states of bipolar disorder.

Authors:  Yusuf Cokunlu; Enver Mirza; Ali Metehan Caliskan; Ikbal Inanli; Ismet Esra Cicek; Muammer Ozcimen; Ibrahim Eren
Journal:  Eye (Lond)       Date:  2021-05-11       Impact factor: 3.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.